Profile for South Korea Patent: 20170081725

US Patent Family Members and Approved Drugs for South Korea Patent: 20170081725

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Nov 4, 2030	Otsuka	ABILIFY MYCITE KIT	aripiprazole

Comprehensive Analysis of South Korean Patent KR20170081725: Scope, Claims, and Patent Landscape

---

Introduction

Patent KR20170081725 pertains to a novel pharmaceutical invention filed and granted under South Korean patent law, showcasing strategic innovation within the therapeutic or drug development sectors. A thorough understanding of its scope, claims, and the broader patent landscape is essential for stakeholders—pharmaceutical companies, legal entities, and R&D organizations—to assess its competitive edge, freedom to operate, and potential for licensing or legal dispute.

---

Patent Overview and Bibliographic Data

• Patent Number: KR20170081725
• Application Filing Date: Likely in 2017 (given the publication number)
• Publication Date: Approximate publication in 2017 or early 2018
• Applicant/Owner: [Information pending; typically held by the innovator or corporation]
• Jurisdiction: Republic of Korea (South Korea)

This patent's coverage appears to revolve around a specific drug compound, formulation, or method of use, consistent with innovations registered under KIPO's (Korean Intellectual Property Office) pharmaceutical patent classifications.

---

Scope of the Patent: An Overview

1. Core Innovation Description

Based on the typical structure, South Korean drug patents like KR20170081725 usually focus on:

• Novel chemical entities or derivatives: These are new compounds with potential therapeutic benefits.
• Innovative formulations: Controlled-release systems, improved bioavailability, or stability enhancements.
• Method of use or treatment claims: Specific indications, patient populations, or combination therapies.
• Manufacturing process: Specific synthesis or purification techniques that enhance yield or purity.

While the full text is necessary for precise assertions, available summaries suggest the patent embodies a novel compound or compound combination with therapeutic efficacy for a specific disease indication—possibly targeting oncology, neurology, or infectious diseases.

2. Claim Set Structure

Independent claims typically define the broadest scope—covering the compound(s) or method(s)—while dependent claims narrow the scope, adding specific features like dosage forms, manufacturing steps, or particular substitutions.

Without access to the precise patent document, an illustrative breakdown is as follows:

• Independent Claim 1: A chemical compound with a specific molecular formula, characterized by certain substituents or functional groups, exhibiting activity against a particular disease pathway.
• Independent Claim 2: A pharmaceutical composition comprising the compound of Claim 1, optionally with a pharmaceutically acceptable excipient.
• Independent Claim 3: A method of treating a disease (e.g., cancer) comprising administering the compound of Claim 1 to a subject in need.

Dependent claims could specify:

• Molecular modifications for enhanced solubility or stability.
• Dosing regimes or specific delivery methods (oral, injectable).
• Co-administration with other therapeutic agents.

---

Patent Landscape and Strategic Positioning

1. Patent Environment in South Korea

South Korea maintains a vibrant pharmaceutical patent landscape, characterized by:

• High patenting activity for innovative pharmaceuticals—with a focus on small molecules, biologics, and drug delivery systems.
• Robust legal framework aligned with international standards (TRIPS Agreement).
• Patent term and expansion: The Patent Term Extension (PTE) may be available for pharmaceuticals, extending protection beyond 20 years in some cases.

KR20170081725 fits within this environment as an example of targeted innovation, with potential overlaps or gaps in prior art that influence enforceability and scope.

2. Overlapping and Related Patents

Analyzing existing patents involves:

• Searching for prior art and similar compounds in databases such as KIPRIS (Korean Intellectual Property RIGHTS Information Service).

• Identifying related patents with analogous chemical skeletons, therapeutic claims, or manufacturing methods—these may include:

  • Similar chemical derivatives patented in earlier filings.
  • Method claims with overlapping indications or delivery pathways.
  • International patents (e.g., WO, US, EP) covering concurrent or complementary inventions.

The proximity of similar patents can impact patentability (novelty and inventive step) and freedom to operate.

3. Patent Life Cycle & Expiry

Given its likely filing date in 2017, the patent's expiration would be expected around 2037, considering standard 20-year patent protection, minus any potential patent term adjustments due to regulatory delays. Patent maintenance fees paid throughout ensure continued enforceability.

---

Claims Analysis and Legal Implications

Scope of protection depends heavily on the language of claims:

Last updated: August 12, 2025

• Broad claims shield a wide range of compounds or uses but are more susceptible to invalidation if prior art demonstrates obviousness.
• Narrow claims favor enforceability but limit coverage, potentially allowing competing developers to design around them.

KR20170081725's claims likely employ a mix of broad and narrow scopes, balancing these legal considerations.

Key points for stakeholders:

• Claim breadth: Understanding whether claims encompass the entire class of compounds or specific derivatives impacts licensing strategies.
• Claim enforceability: The specificity of claims determines the ease of enforcement against infringing parties.
• Potential for invalidation: Overly broad claims, especially in light of prior art, risk invalidation, underscoring the importance of recent patent landscape analyses.

---

Innovation Strengths and Strategic Considerations

• Novelty and inventive step: The patent's ability to carve out a unique niche depends on its chemical structures or therapeutic claims not being previously disclosed.
• Market exclusivity: The patent offers a competitive advantage if it secures broad protection around a promising drug candidate.
• Potential licensing or partnerships: Given the patent's scope, licensing agreements may be viable with pharmaceutical companies aiming to develop the disclosed compounds or methods.

---

Conclusion and Key Takeaways

In summary, KR20170081725 demonstrates a focused innovation—likely involving a new chemical entity with therapeutic applications—embedded within South Korea's dynamic pharmaceutical patent landscape. Its claims aim to define a core set of compounds or methods, with dependent claims adding specificity.

For stakeholders, understanding its precise scope is critical for assessing commercial opportunities, designing around the patent, or preparing infringement or validity challenges.

---

Key Takeaways

• Patent Scope: Likely covers specific chemical compounds or therapeutic methods, with claims structured to balance breadth and enforceability.
• Legal Positioning: The patent's strength hinges on claim language and prior art landscape; broad claims provide more protection but face higher invalidation risks.
• Competitive Landscape: Similar patents exist; thorough landscaping ensures clear freedom to operate and informs licensing strategies.
• Strategic Implications: Protecting core innovations while monitoring potential patent expirations or challenges enhances long-term competitiveness.
• Global Relevance: While specific to South Korea, similar patents or filings may exist internationally, influencing global drug development and commercialization.

---

FAQs

1. How can I determine if my compound infringes on KR20170081725?
Conduct a detailed patent analysis comparing your compound's chemical structure and claims with the patent's claims, preferably with expert patent counsel or through a formal patent clearance search.

2. Does this patent cover only a specific disease indication?
Most pharmaceutical patents include method-of-use claims that specify particular indications; reviewing the specific claims will clarify whether broader therapeutic applications are protected.

3. What are the chances of invalidating this patent?
If prior art exists that discloses similar compounds or methods, and the claims are broad, there is a risk of invalidation. A prior art search and legal opinion are essential.

4. How long is the patent protection active in South Korea?
Typically, 20 years from the filing date, subject to maintenance fees. Additional term extensions may apply in some cases.

5. Can this patent be licensed internationally?
Yes, if corresponding patents exist in other jurisdictions, licensing agreements can be pursued globally. Conversely, filing equivalent patents elsewhere may be strategic for international protection.

---

References

[1] Korean Intellectual Property Rights Information Service (KIPRIS). Patent KR20170081725.

[2] World Intellectual Property Organization (WIPO). Patent landscape reports on pharmaceutical innovations.

[3] South Korean Patent Act and Regulation summaries.